| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |